Table:
begin	end	state
1	11	cytoplasmic
12	32	transmembrane
33	42	non-cytoplasmic
43	67	transmembrane
68	86	cytoplasmic
87	109	transmembrane
110	146	non-cytoplasmic
147	165	transmembrane
166	171	cytoplasmic
172	196	transmembrane
197	216	non-cytoplasmic
217	241	transmembrane
242	252	cytoplasmic
253	277	transmembrane
278	302	non-cytoplasmic
303	333	transmembrane
334	344	cytoplasmic
345	369	transmembrane
370	382	non-cytoplasmic
383	403	transmembrane
404	422	cytoplasmic
423	444	transmembrane
445	446	non-cytoplasmic

Input:
>WP_085544283.1 NCBI__GCF_900177735.1:WP_085544283.1
MKAESSRGEWSSKIGFILAAAGSAIGLGSIWRFPYITGQSGGAVFVLVYLFLVFTIGISL
MMAEIVIGKKGRLNAVGSFRRLGGKHWGLVGWIGVIAAFVILSYYGVIGGWTMAYVLKSF
TGLISTSGSGEVAKIFEAFISDGKQMLFYQGLFMAATVIVVFRGVSGGIERLCTFCMPAL
FILMILLIGRALTLPGAMEGVVFFLKPDFSKLSGEVVLSAMGQAFFSLSLGIGAMVIYGS
YLPDKTDIPKASLQICFLTFMISLMAGLIIFPSLFAFGMEPGAGAGLTFITLPVVFAKMP
GGVLWAASFFVLFFFAALTSSVSLLEVVVSYMIDSLGWDRKKATILLGVLISVVGIPSAL
SQGAVTINVFGVSFLDAADFFASNLLMPAGGFLTAVFIGWVAYSAGFDGITGGGAVPFRH
KKLWMFILRFIAPVCILVIFIAGLKW

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server